Quick Hits

• Oil supply under attack. Saudi Arabia temporarily shut its East-West pipeline after a drone attack, per Reuters via r/investing — notable because the line is Riyadh's workaround to bypass the Strait of Hormuz while Gulf shipping is disrupted. Oil prices are soaring amid the broader Middle East tension, feeding the inflation scare.
• The 5% threshold looms. The 10-year Treasury yield is "sitting on the doorstep of 5%," and MarketWatch notes the bond market is pushing for Fed rate hikes even though hikes won't bring down gas prices — a configuration the outlet flags as a warning sign for stocks. It follows a discouraging inflation report this week.
• Citi's AI warning. Citigroup cautions that AI has carried the stock market, and a pause in AI model development could pull the rug out — earnings revisions have been crucial to this year's gains.
• Anthropic profitable — with an asterisk. A report says the AI lab was profitable for a second straight quarter, but MarketWatch flags "a very big caveat." Meanwhile, OpenAI's Sam Altman ruled out a 2026 IPO, calling it "ill-advised" given AI-safety concerns.
• Novartis stumbles again. The Swiss pharma reported its third clinical failure in seven days, triggering ripples through one of the most hotly anticipated multibillion-dollar drug races — with read-through for Eli Lilly (LLY).

Markets Overview

The tape has been rough for a few weeks even though the S&P 500 is still up roughly 11% year-to-date and hovering near record levels, per Motley Fool — an interruption, not (yet) a reversal. The pressure points: an oil spike on Middle East tensions and a hot inflation print that has yields testing 5%.

Berkshire Hathaway (BRK.B) has gone almost nowhere in 2026 — B shares near $510, up about 2% — trailing the S&P 500 by roughly 10 points. Motley Fool notes history says that gap doesn't last. Growth names show the strain more acutely: Netflix (NFLX) is down 43% from its June 2025 record even as the S&P gained 23% over the same span, and Archer Aviation (ACHR) has collapsed from $14.62 last October to about $5.61 — turning $10,000 into roughly $3,840.

Earnings Reports

• Coda Octopus (CODA) posted GAAP EPS of $0.12, in line, on revenue of $7.7 million — a $0.44 million beat, per Seeking Alpha.
• Oracle (ORCL) can't get traction despite soaring revenue and a robust backlog; shares are down about 50% over the past year as investors continue to fret, prompting Fool to ask whether it's time to back up the truck.
• On the outlook front: Fool predicts ServiceNow's (NOW) AI business triples before 2029 after a standout AI disclosure in its July quarter; DocuSign (DOCU) is racing to rebrand beyond e-signature with AI driving its revenue outlook; and Planet Labs (PL) is leaning on government contracts for growth.

Fed & Economic Data

The macro debate is the day's dominant story. MarketWatch's core point: rate hikes won't lower gas prices, but the bond market is demanding them anyway — and with the 10-year knocking on 5%, that's a headwind equities can't ignore. Motley Fool adds context: oil is soaring on Middle East tension and this week's inflation report was discouraging.

The political overlay is coming. Ahead of the Nov. 3 midterms, Fool warns a proposed $5,000 "Trump dividend" could send inflation and bond yields "into the stratosphere." Meanwhile, r/investing is debating the opposite scenario — that the Fed ultimately cuts and inflates the debt away, 1940s-style yield-curve control. For retirees, Social Security's biggest announcement of the year — the COLA — lands in about a month, after this year's adjustment disappointed.

Hot Sectors

• Memory chips are 2026's engine — and getting crowded. Memory and storage names are driving markets this year on AI infrastructure demand. Micron (MU) has gained more than 500% over the past year to $975, but Fool flags that Nvidia's latest signal points to serious downside risk for the stock before 2029 is over.
• Healthcare is bifurcating. Legacy blockbusters are facing generic competition while chronic-care treatments boom — the tension at the heart of Fool's AbbVie (ABBV) vs. Novo Nordisk (NVO) debate. Novartis's (NVS) triple pipeline failure in a week is reshuffling one multibillion-dollar race, with implications for Lilly.
• Analyst call of the day: Goldman Sachs added Vertex Pharmaceuticals (VRTX) — trading at $546 against street targets spanning $350 to $672 — to its Conviction List.

Stock News

• OpenAI stays private. Altman says an IPO isn't in the cards this year, arguing ramped-up AI-safety concerns make now an "ill-advised" time to go public. The Reddit crowd is already speculating about rival Anthropic's IPO path instead.
• Dell (DELL) hit an all-time high, jumping more than 8% for the week after analysts highlighted its AI-fueled expansion prospects.
• Insider sale: Box (BOX) CEO Aaron Levie sold 15,000 shares worth over $500,000 on Sept. 10, days after the stock touched a 52-week high, per an SEC Form 4.
• Fool lined up SpaceX (SPCX) and Apple (AAPL) as two of the world's largest public companies — with Wall Street seeing strong upside for one and staying neutral on the other.
• Dividend declarations: Malaga Financial and Village Super Market at $0.25 each; Bentley Systems (BSY) at $0.07.

Market Analysis

The day's three threads — oil, yields, and AI — are really one question: can equity valuations hold if the inflation shock forces the Fed's hand? Citi's warning crystallizes the risk: earnings revisions powered this year's gains, and an AI development pause would hit revisions directly. Motley Fool notes Warren Buffett is sending a stark warning to investors and that history says he's right.

The counterweight, also from Fool: even investors who bought at prior market peaks have historically fared better than expected — the bigger risk to returns is behavioral, the discipline point Buffett himself emphasizes.

One contrarian data point from r/investing: a tracked Butte County, California tax-deed auction saw 74% of 105 lots receive no bids at all — a reminder that not every corner of the market is frothy.

Watch this week: the Saudi pipeline's status and Strait of Hormuz shipping, whether the 10-year breaks 5%, Fed commentary against market pricing for hikes, midterm fiscal-promise escalation ahead of Nov. 3, October's Social Security COLA announcement, and any further detail on Anthropic's profitability caveat.